Rhizen, TG Therapeutics deal

TG Therapeutics exercised an option under a 2012 deal to license exclusive,

Read the full 123 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE